F16.12

Clinical Causes: Curiosity or desire for altered perceptions Peer pressure or social influences Mental health issues such as anxiety or depression Substance dependency and addiction tendencies Environmental factors or traumatic experiences Availability and accessibility of hallucinogenic substances Underlying genetic vulnerabilities

Key Symptoms: Visual or auditory hallucinations, such as seeing or hearing things that aren't there Altered perceptions of time and space Feelings of euphoria or heightened sense of awareness Distorted thinking or confusion Impaired motor skills and coordination Dilated pupils and increased heart rate Nausea, dizziness, or trouble with coordination Anxiety, paranoia, or panic attacks during intoxication Possible emotional lability or rapid mood swings

Diagnosis Path: Diagnosis typically involves a comprehensive medical and psychological assessment by a healthcare professional. This assessment includes reviewing the individual's substance use history, observing physical and behavioral symptoms, and ruling out other potential causes for the symptoms. Laboratory tests such as blood or urine screens may be used to detect recent hallucinogen use. Mental health evaluations can also determine any co-occurring disorders or substance dependencies.

Treatment Protocols: Detoxification: supervised medical process to safely manage withdrawal symptoms Psychotherapy: cognitive-behavioral therapy (CBT) and counseling to address psychological dependence and underlying issues Support groups: peer support to reinforce abstinence and recovery Educational programs: to inform about the risks and effects of hallucinogens Addressing co-occurring mental health conditions, such as depression or anxiety Medication management: sometimes used to treat symptoms or co-occurring disorders, but no specific drugs are approved solely for hallucinogen dependence